Trillium Therapeutics Inc

NASDAQ:TRIL   3:59:55 PM EDT
9.77
+0.03 (+0.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Trillium Therapeutics Inc Stock, NASDAQ:TRIL

2488 Dunwin Drive, Mississauga, Ontario L5L 1J9
Canada
Phone: +1.416.595.0627
Number of Employees:

Description

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.